Globalization Of Clinical Trials Makes Case For Clinical Trial Management Systems
Contract research organizations (CROs) hope to obtain an edge in the highly competitive healthcare industry by using technology to shorten project times, improve data quality, and thus, differentiate services. As clinical trials globalize, sponsor companies and CROs increasingly look for tools that will help them simultaneously view, manage and discuss these trials across multiple sites.
St. Jude Medical Announces CE Mark Approval And European Launch Of TigerWire Steerable Guidewire
St. Jude Medical, Inc. (NYSE: STJ) announced European CE Mark approval and the European launch of the TigerWire™ Steerable Guidewire.
AngioScore Announces Initiation Of Enrollment In Multi-Center Coronary Artery Bifurcation Trial
AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, announced the successful initiation of enrollment in the AngioSculpt Scoring Balloon Catheter Multi-Center Coronary Bifurcation Study, or AGILITY trial.
NIH Initiates Phase 1 Safety Study Of AVANT's Oral Combined Enterotoxigenic E. coli-Cholera Vaccine
AVANT Immunotherapeutics, Inc.
Callisto Pharmaceuticals Opens Phase I Clinical Trial Of SP-304 To Treat Chronic Constipation And Irritable Bowel Syndrome
Callisto Pharmaceuticals, Inc. (AMEX: KAL; FWB: CA4) announced today that through its wholly-owned subsidiary, Synergy Pharmaceuticals, Inc., it initiated oral dosing of healthy volunteers in a Phase I clinical trial of SP-304. The primary objective of the Phase I clinical trial is to assess safety and tolerability of an oral dose of SP-304 in healthy adult volunteers.
Alzheimer's Society Comment On 'Charging Into Poverty?' UK
This report confirms the shocking truth that social care charges are hitting vulnerable older people harder than ever. There are 700, 000 people living with dementia in the UK and this will rise to over a million people in less than 20 years.
VIVUS Announces The Podium Presentation Of Phase 2 Data For Qnexa In Type 2 Diabetics At The American Diabetes Association Meeting
VIVUS, Inc (NASDAQ: VVUS) a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that the results from OB-202, a 28-week, placebo controlled, safety and efficacy phase 2 study to determine glycemic control in type 2 diabetics treated.
Government Of Japan Provides US 4.33 Million To Support Maternal And Child Survival In Afghanistan
Health programmes in Afghanistan will receive a boost with a new US$ 4.33 million grant from the Government of Japan. Under a new agreement signed with UNICEF today, approximately 7.5 million children in the Islamic Republic of Afghanistan will benefit from improvements in infectious disease prevention and control as a result of the funding.
Mental Health America Honors Congressman Jim Ramstad For Career Leadership On Mental Health Parity
Mental Health America will honor Congressman Jim Ramstad (R-Minn.) with its Career Achievement Award for his invaluable contributions and untiring leadership in championing parity legislation to improve access to mental health and addiction treatment.
Reduced Hepatitis C Viral Level Achieved With DNA Vaccine Delivered By Inovio Biomedical's Electroporation Delivery System
Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced that its partner, Tripep AB, reported preliminary results indicating a dramatic reduction in hepatitis C viral load in its ongoing phase I/II clinical stu.